Andere talen ClouDr Group Limited

Aandelen

9955

KYG2216H1011

Beurs gesloten - Hong Kong S.E. Andere beurzen 10:08:16 02-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
3,09 ^HKD	+3,00%		+27,16%	-54,89%

22/03	Nettoverlies ClouDr Group daalt met 81% in 2023 terwijl de omzet met 23,5% stijgt	MT
21/03	ClouDr Group Limited rapporteert resultaten voor het volledige jaar eindigend op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

ClouDr Launches Digital Employee to Improve Online-to-Offline Operation Services	15/04
ClouDr Group's Net Loss Shrinks 81% in 2023 as Revenue Rises 23.5%	22/03
ClouDr Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023	21/03
ClouDr Launches Diabetes Tablets; Shares Up 3%	11/03
ClouDr Group Limited Announces Launch of Proprietary Product, Hetangjin Dapagliflozin Tablets	10/03
ClouDr Group Limited Enters into A Non-Legally Binding Strategic Cooperation Agreement with China Resources Kunming Shenghuo Pharmaceutical Co., Ltd	05/03
ClouDr Buys Back Shares	25/01
ClouDr Group Trustee Buys 1.3 Million Shares Under Award Scheme	18/01
ClouDr Unit to Get 200 Million Yuan Capital Injection	12/01
ClouDr Buys Back Shares for Incentive Scheme	11/01
ClouDr Group Applies to Register Diabetes Digital Therapeutics in China	03/01
ClouDr Group Limited Completes the Application for Registration as A Medical Device in the People's Republic of China in Respect of ClouDT-01	03/01
ClouDr Group to Buy Up to HK$80 Million of Shares	29/12
ClouDr Signs Marketing Deal With Shanxi Jinbo Bio Pharmaceutical	28/12
ClouDr Group Limited Enters into a Non-Legally Binding Strategic Cooperation Agreement with Shanxi Jinbo Bio-Pharmaceutical Co., Ltd	27/12
Cloudr Group Limited Announces Resignation of Liu Mengya as Joint Company Secretary	19/12
ClouDr Group Signs Digital Marketing Agreement with Pharmaceutical Company	30/11
ClouDr Says New Evidence Shows Ischelium Drug's Efficacy on Cognitive Improvement	16/11
ClouDr Group Limited Announces New Efficacy of Ischelium on Brain Covidative Fund Approval	16/11
ClouDr to be Added in MSCI China Small Cap Index	15/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen ClouDr Group Limited

Aandelen

9955

KYG2216H1011

Andere talen

Filters